Published date: Mar 08 2023

Journal Title: KnE Medicine

Issue title: 2nd International Conference on Medical Health Science (2nd ICMEDH)

Pages: 82–90

DOI: 10.18502/kme.v3i2.13039

Ro'di Nur Fajrirodinurfajri19@gmail.comUniversity of Muhammadiyah Malang General Hospital

Achmad Rifa'iUniversity of Muhammadiyah Malang General Hospital

Anggita PuspitasariMedical Faculty University of Muhammadiyah Malang

Chronic Kidney Disease (CKD) is a clinical condition in which kidney function and/or structure is characterized by irreversible and slow, progressive evolution. CKD cases in Indonesia in 2018 amounted to 3.8% of the total population (713,783 cases). Prevalence of CKD patients with Hepatitis B and/or Hepatitis C at UMM General Hospital has never been reported before. Data were taken from the medical records of UMM General Hospital. Characteristics of the patients were age, gender, aetiology, vascular access and duration of hemodialysis. The results of the laboratory examinations analyzed were HBsAg and Anti-HCV on CKD patients who underwent hemodialysis every 6 months, starting from January 2020. Data were analyzed with descriptive analysis using SPSS v25. The demographic proportion of CKD patients undergoing hemodialysis was highest in the 50-59 year age group (33.8%). Males were more than females (85 patients, 53.1%). The most common aetiology of CKD at UMM General Hospital was caused by hypertension (92 patients, 57.5%). Vascular access mostly used was AV shunt (107 patients, 66.9%). 107 (66.9%) patients had undergone hemodialysis for 1-5 years. In January-June 2022, there were 2 (1.25%) Hepatitis B patients with CKD and 8 (5%) CKD patients with Hepatitis C. The majority of CKD patients at UMM General Hospital were male patients aged 50-59 years, having had hemodialysis for 1-5 years, using AV Shunt, with the most common cause being hypertension. In January-June 2022, there were 1.25% CKD patients with Hepatitis B and 5% CKD patients with Hepatitis C.

Keywords: CKD, hemodialysis, Hepatitis B, Hepatitis C

[1] Braun MM, Khayat M. Kidney Disease: Chronic Kidney Disease. FP Essent. 2021 Oct;509 Suppl 1:20–5.

[2] Jatim R. Laporan Provinsi Jawa Timur RISKESDAS 2018 [Internet]. Kementerian Kesehatan RI. 2018. 191 p. Available from: https://drive.google.com/drive/folders/1XYHFQuKucZIwmCADX5ff1aDhfJgqzI-l%0A

[3] Sharma SK. Medical-Surgical Nursing. 2019.

[4] Kementerian Kesehatan RI. InfoDATIN Pusat Data dan Informasi Kementerian Kesehatan RI Situasi Penyakit Hepatitis B di Indonesia Tahun 2017. 2017;9–25.

[5] Kementerian Kesehatan RI. InfoDATIN Pusat Data dan Informasi Kementerian Kesehatan RI, Situasi dan Analsisis Hepatitis. 2014.

[6] Fabrizi F, Martin P, Messa P. Hepatitis B and hepatitis C virus and chronic kidney disease. Acta Gastroenterol Belg. 2010;73(4):465–71.

[7] Suandewi DA, Sugiarta IG, Astawa NT, Ekariawan IP. Profil penderita Chronic Kidney Disease (CKD) stadium 5 yang menjalani hemodialisis reguler di Rumah Sakit Umum Daerah (RSUD) Klungkung, Bali, Indonesia. Intisari Sains Medis. 2020;11(2):613.

[8] Bawazier LA. Epidemiological Profile of Twice per Week Hemodialysis Patients of Top Referral National Hospital in Indonesia. eJournal Kedokt Indones. 2018;6(2).

[9] Pugh D, Gallacher PJ, Dhaun N. Management of Hypertension in Chronic Kidney Disease [Internet]. Drugs. 2019 Mar;79(4):365–79.

[10] Sebayang AN, Hidayat NA. Arteriovenous Shunt Sebagai Akses Hemodialisis Pada Pasien Penyakit Gagal Ginjal Kronis. Jimki. 2020;8(2):112–6.

[11] Depkes RI. Pedoman Pelayanan Hemodialisis di Sarana Pelayanan Kesehatan. DirDepkes RI (2008) Pedoman Pelayanan Hemodialisis di Sarana Pelayanan Kesehatan Direktorat Bina Pelayanan Med Spes Direktorat Jenderal Bina Pelayanan Med Dep Kesehat Republik Indones. 2008;8–9. Available from: https://www.pernefri.org/konsensus/PEDOMANPelayananHD.pdf

[12] Hong YS, Ryu S, Chang Y, Caínzos-Achirica M, Kwon MJ, Zhao D, et al. Hepatitis B virus infection and development of chronic kidney disease: a cohort study. BMC Nephrol. 2018 Dec;19(1):353.

[13] Fabrizi F, Donato FM, Messa P. Association between hepatitis B virus and chronic kidney disease: a systematic review and meta-analysis. Ann Hepatol. 2017 Jan- Feb;16(1):21–47.

[14] Du Y, Zhang S, Hu M, Wang Q, Liu N, Shen H, et al. Association between hepatitis B virus infection and chronic kidney disease: A cross-sectional study from 3 million population aged 20 to 49 years in rural China. Medicine (Baltimore). 2019 Feb;98(5):14262.

[15] Liu Y, Wang X, Xu F, Li D, Yang H, Sun N, et al. Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China [Internet]. J Clin Transl Hepatol. 2022 Apr;10(2):238–46. Available from: https://www.doi.org/10.14218/JCTH.2021.00082

[16] Santos MG, Danguilan RA, Que ET, Balmaceda RP, Padilla BS. Prevalence of hepatitis B and hepatitis C in haemodialysis patients. Nephrology (Carlton). 2019;4(1–2):101–4.

[17] Tim T, Dan P, Pedoman P, Hepatitis P, Di V. Pedoman pengendalian hepatitis virus. 2012.